Stockreport

4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program [Yahoo! Finance]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF NEWTON, Mass., April 14, 2026 BUSINESS WIRE 4D Path , a company dedicated to personalizing cancer care through a novel, physics-informed approach to predicting tumor re [Read more]